Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial-Reference-Cited by-同舟云学术

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial

Published:2016-01-05 Issue:1 Volume:11 Page:e0143490
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Smith Robert C.,Amiaz Revital,Si Tian-Mei,Maayan Lawrence,Jin Hua,Boules Sylvia,Sershen Henry,Li Chunbo,Ren Juanjuan,Liu Yanhong,Youseff Mary,Lajtha Abel,Guidotti Alessandro,Weiser Mark,Davis John M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo smoking cessation;D Gonzales;JAMA,2006

2. Efficacy of varenicline, and alpha4beta2 nicotinic acetylcholine receptor partial agonist,vs placebo or sustained-release bupropion for smoking cessation;D Jorenby;JAMA,2006

3. Varenicline is a parietal agonist at {alpha]4{beta}2 and a full agonist at {alpha}7 neuronal nicotinic receptors;K Mihakak;Mol Pharmcol,2006

4. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia;R Freedman;Journal of Chemical Neuroanatomy,2000

5. Evidence in postmortem brain tissue for decreased numbers of hippocampus nicotinic receptors in schizophrenia;R Freedman;Biological Psychiatry,1995

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for smoking cessation in inpatient psychiatry settings;Cochrane Database of Systematic Reviews;2024-09-04

2. Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes;PeerJ;2023-11-21

3. Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review;Neuropsychopharmacology Reports;2023-10-04

4. Modern synthesis of cognitive enhancers: cholinergic ligands;Russian Chemical Bulletin;2023-04

5. Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update;Current Neuropharmacology;2023-02